Pharmaceutical manufacturing

This March 26, 2018 photo provided by Ashley Atwater shows her mother, Sally Atwater, outside her home in the Georgetown area of Washington, a few days after leaving the hospital. Atwater's doctor spent two months on calls, messages and dozens of pages of forms to get her an experimental drug he thinks can fight the lung cancer that has spread to her brain and spine. (Courtesy Ashley Atwater via AP)
June 03, 2019 - 9:02 am
CHICAGO (AP) — U.S. drug regulators are launching a project aimed at giving more cancer patients a chance to try treatments that are not yet on the market but that have shown some promise in early testing. Currently, when patients want what's called "compassionate use" access to an experimental...
Read More
May 29, 2019 - 11:24 am
PHILADELPHIA (AP) — The U.S. attorney's office in Philadelphia says a pharmaceutical company is agreeing to pay $3.5 million to settle claims it paid kickbacks to dermatology providers to encourage them to prescribe their drugs. U.S. Attorney William McSwain said Wednesday the matter involved...
Read More
Two people ask to take a photo with House Judiciary Committee Chairman Jerrold Nadler, D-N.Y., center, as the Senate and the House of Representatives shut down for the week-long Memorial Day recess, at the Capitol in Washington, Thursday, May 23, 2019. Rep. Nadler, whose district covers parts of Manhattan and Brooklyn in New York, has gained notoriety by leading one of the House committees investigating President Donald Trump. (AP Photo/J. Scott Applewhite)
May 23, 2019 - 2:49 pm
WASHINGTON (AP) — Plunging ahead despite paralyzing partisanship in the nation's capital, senior lawmakers of both parties Thursday proposed legislation to tackle "surprise medical bills" and other concerns, from prescription drug costs to uneven vaccination rates. The draft bill from Sens. Lamar...
Read More
May 20, 2019 - 3:12 pm
WASHINGTON (AP) — The Supreme Court said Monday that a judge must decide whether a dispute between drugmaker Merck and patients who alleged they were injured by its bone-strengthening drug Fosamax can go forward. All nine justices agreed that the case should go back to a lower court for further...
Read More
Rep. Anna Eshoo, D-Calif., right, chair of the House Health Subcommittee, says President Donald Trump and Attorney General William Barr want to take a sledgehammer to health care, as she joins, from left, Rep. Lisa Blunt Rochester, D-Del., House Speaker Nancy Pelosi, D-Calif., and Senate Minority Leader Chuck Schumer, D-N.Y., at a Democratic event ahead of a House floor vote on the Health Care and Prescription Drug Package, at the Capitol in Washington, Wednesday, May 15, 2019. (AP Photo/J. Scott Applewhite)
May 16, 2019 - 8:07 pm
WASHINGTON (AP) — Democrats pushed legislation buttressing the 2010 health care law and curbing prescription drug prices through the House Thursday, advancing a bill that has no chance of surviving in the Senate or getting President Donald Trump's signature and seemed engineered with next year's...
Read More
FILE - This July 6, 2017 file photo shows prescription drugs in a glass flask at the state crime lab in Taylorsville, Utah. Attorneys general from more than 40 states are alleging the nation's largest generic drug manufacturers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs, including treatments for diabetes, cancer, arthritis and other medical conditions. The lawsuit, filed in federal court Friday, May 10, 2019 also names 15 individual senior executives responsible for sales, marketing and pricing. (AP Photo/Rick Bowmer, File)
May 11, 2019 - 3:13 pm
BOSTON (AP) — Attorneys general from more than 40 states are alleging the nation's largest generic drug manufacturers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs, including treatments for diabetes, cancer, arthritis and other medical conditions...
Read More
President Donald Trump speaks during a event on medical billing, in the Roosevelt Room of the White House, Thursday, May 9, 2019, in Washington. (AP Photo/Evan Vucci)
May 09, 2019 - 12:59 pm
WASHINGTON (AP) — The Latest on President Donald Trump's effort to limit "surprise medical bills" (all times local): 1 p.m. President Donald Trump is ratcheting up pressure on the pharmaceutical industry to lower prices and announcing a new effort to end "surprise medical bills" for patients with...
Read More
FILE - In this March 13, 2019, file phtooHealth and Human Services Secretary Alex Azar testifies before a House Appropriations subcommittee on Capitol Hill in Washington. Azar says drugmakers will soon have to reveal prices of their prescription medicines in those ever-present TV ads. The Trump administration will issue final regulations on May 8 requiring drug companies to disclose list prices of medications costing more than $35 for a month’s supply. Azar tells The Associated Press if drugmakers are scared to put prices in ads that means they should lower those prices. (AP Photo/Susan Walsh, File)
May 08, 2019 - 3:28 pm
WASHINGTON (AP) — TV pitches for prescription drugs will soon include the price, giving consumers more information upfront as they make medication choices at a time when new drugs can carry anxiety-inducing prices. Health and Human Services Secretary Alex Azar said Wednesday the Trump...
Read More
Democratic presidential candidate Sen. Bernie Sanders, I-Vt., Bernie Sanders speaks during a rally at Discovery Green on Wednesday, April 24, 2019, in Houston. (Brett Coomer/Houston Chronicle via AP)
May 01, 2019 - 4:12 pm
WASHINGTON (AP) — Congressional budget experts said Wednesday that moving to a government-run health care system like "Medicare for All" could be complicated and potentially disruptive for Americans. The report from the nonpartisan Congressional Budget Office was a high-level look at the pros and...
Read More
In this Friday, April 26, 2019 photo, a box of RELPAX migraine pills manufactured by Pfizer are arranged for a photo in Doral, Fla. Pfizer Inc. reports financial results Tuesday, April 30. (AP Photo/Wilfredo Lee)
April 30, 2019 - 8:13 am
NEW YORK (AP) — Higher prescription drugs sales and restrained spending together gave drugmaker Pfizer a 9% jump in first quarter profit as it easily topped analysts' profit expectations. The maker of blood thinner Eliquis and Xeljanz for rheumatoid arthritis saw their sales each jump by 30% or...
Read More

Pages